A large volume variation of the classic Molly® auto-injector, the Molly® 2.25 is designed to accommodate fill volumes up to 2.25mL.
SHL provides design, development and manufacturing services for advanced drug delivery systems.
The company’s core competencies comprise services in the fields of medtech and patient care. It works closely with leading biotechnology and pharmaceutical companies to develop drug delivery devices, including compact disposable auto-injectors, reusable pen injectors and complex inhaler systems.
These devices use standard pre-filled syringes and cartridges, as well as novel primary containers.
Research, innovation and design services for drug delivery devices
SHL has always invested significantly in research and development (R&D). This investment has especially intensified over the past ten years, allowing the company to upgrade its broad pipeline of next-generation drug delivery devices.
These innovative devices include advanced reusable and disposable injectors that can be enhanced through digital implementations and can accommodate high-volume and high viscosities.
SHL’s investments have strengthened its support in the advancement of drug development and digital healthcare.
In-house manufacturing of auto-injectors and inhaler systems
SHL manufactures high-quality, high-volume drug delivery devices, and is ranked among the top global producers.
Central to its success is the vertical integration of key manufacturing capabilities to ensure quality and time-to-market.
Developing drug delivery devices in-house allows SHL to customise existing platforms in its pipeline, or develop completely bespoke devices based on the unique requirements for its clients.
Key manufacturing capacities include:
- Tooling: Advanced in-house tooling centre for drug delivery devices
- Moulding: Extensive range of moulding solutions
- Automation: Customised assembly and testing equipment
- CNC machining: High-precision CNC machining centres
- Metrology: Precision inspection of product components and equipment parts
- Assembly: Semi-automatic and fully-automatic assembly solutions
Drug delivery device assembly, labelling and packaging
SHL provides final assembly, labelling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries.
These services were established to streamline the production and distribution processes for SHL’s injection products to improve end-product quality and offer faster time-to-market.
By integrating an additional piece of the supply chain, SHL offers a fully comprehensive experience for its customer’s drug delivery products.
Key abilities include:
- Device and primary packaging characterisation
- Final assembly of auto-injectors or pen injectors
- Labelling and secondary packaging and/or kitting of assembled devices
Commercialisation solutions for medicine delivery devices
SHL’s international team of dedicated professionals ensures that customer expectations are met and final products are delivered at optimum quality and speed.
The company provides a comprehensive range of services, including:
- Quality systems: International Standardisation Organisation (ISO) 13485 and US Food and Drug Administration (FDA) 21 Code of Federal Regulations (CFR) 820-compliant systems
- Regulatory and compliance: Support for regulatory lifecycle management
- Intellectual property (IP): Comprehensive strategy to safeguard SHL IPs
- Project management: Dedicated professionals to ensure success of customer projects
- Global supply chain: Scalable storage and customisable global shipping strategies
With locations in Taiwan, Sweden, Switzerland, China and the US, SHL’s experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for clients globally.
As the company is determined to provide the most comprehensive range of solutions and services, it maintains all key capabilities and processes in-house to ensure the best quality and time-to-market.
With more than 4,000 staff worldwide, SHL’s organisation consists of several distinct group companies, including:
- SHL Medical: Designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labelling and packaging services for leading pharmaceutical and biotech companies across the globe
- SHL Healthcare: Develops and manufactures equipment solutions for home, hospital and long-term care use
- SHL Technologies: Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
Despite being founded in an age when medical devices were more about getting the job done than providing optimum patient experience, SHL Group has from the very beginning placed emphasis on users and usability.
SHL has extensive experience in the parenteral arena. In this article, SHL details its latest offerings in the world of biologics, as well as its partnership with speciality digital healthcare start-up QuiO to develop injectables in the connected healthcare space.
SHL will join the 2020 Parenteral Drug Association’s annual Universe of Pre-Filled Syringes and Injection Devices virtual event with the launch of our virtual experience platform.
SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging.
SHL will exhibit at Pharmapack Europe 2020 between 5-6 February in Paris, France.
On 5 November, SHL Group held the inauguration of its new Liufu site in Taoyuan City, Taiwan.
SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) Conference on 7-8 October, showcasing at Booth 24, the Renaissance Boston Waterfront Hotel in Boston.
SHL will exhibit at the 2019 Contracting and Outsourcing Conference & Tabletop Exhibition on 26 September in New Brunswick, New Jersey. For this two-day conference, the company is set to showcase its quality offerings in final assembly, labelling and packaging at the one-day tabletop exhibition.
SHL Group is exhibiting at the 2019 BIO International Convention in Philadelphia, Pennsylvania, US.
SHL is primed to exhibit at the Prefilled Syringe Seminar in Tokyo.
SHL Group will lead a webinar titled ‘Personalization of Patient Care – The Next Frontier in Drug Delivery’.
SHL Group has announced that it will make its first appearance at the 21st Asia Pacific League of Associations for Rheumatology Congress.
SHL Group is looking forward to exhibiting at the 2019 Pharmapack, Europe's dedicated pharmaceutical packaging and drug delivery event from 6-7 February in Paris, France.
SHL is set to present its market-leading auto-injector offerings and expertise in final assembly and packaging services at the Drug Delivery Partnerships (DDP) conference this year.
SHL Group will take part in the Universe of Pre-Filled Syringes and Injection Devices conference, which is Parenteral Drug Association’s largest event this year and will take place in October.
SHL Group has announced it will be participating in the BIO International Convention in Boston, Massachusetts, US.
SHL Group has announced it will be exhibiting at the Prefilled Syringe Seminar 2018 in Tokyo.
SHL Group has announced it will hold a live webinar to discuss how pharmaceutical companies can leverage a preconfigured device technology to bring their innovative drug formulations to market more efficiently.
SHL has announced it is exhibiting at the 2018 Drug Delivery Partnerships (DDP) conference in Florida.
No 36 Liufu Rd, Luzhu District
Taoyuan City 338
PO Box 1240, Augustendalsvagen 7
SE-131 28 Nacka Strand
588 Jim Moran Boulevard
Deerfield Beach, FL 33442
United States of America
Bld 8, A-6 Tongfuyu Industrial Park
Bu-Chong, Shajing Town, Baoan District